Literature DB >> 22226248

A controlled study of the effectiveness of an adaptive closed-loop algorithm to minimize corticosteroid-induced stress hyperglycemia in type 1 diabetes.

Joseph El Youssef1, Jessica R Castle, Deborah L Branigan, Ryan G Massoud, Matthew E Breen, Peter G Jacobs, B Wayne Bequette, W Kenneth Ward.   

Abstract

To be effective in type 1 diabetes, algorithms must be able to limit hyperglycemic excursions resulting from medical and emotional stress. We tested an algorithm that estimates insulin sensitivity at regular intervals and continually adjusts gain factors of a fading memory proportional-derivative (FMPD) algorithm. In order to assess whether the algorithm could appropriately adapt and limit the degree of hyperglycemia, we administered oral hydrocortisone repeatedly to create insulin resistance. We compared this indirect adaptive proportional-derivative (APD) algorithm to the FMPD algorithm, which used fixed gain parameters. Each subject with type 1 diabetes (n = 14) was studied on two occasions, each for 33 h. The APD algorithm consistently identified a fall in insulin sensitivity after hydrocortisone. The gain factors and insulin infusion rates were appropriately increased, leading to satisfactory glycemic control after adaptation (premeal glucose on day 2, 148 ± 6 mg/dl). After sufficient time was allowed for adaptation, the late postprandial glucose increment was significantly lower than when measured shortly after the onset of the steroid effect. In addition, during the controlled comparison, glycemia was significantly lower with the APD algorithm than with the FMPD algorithm. No increase in hypoglycemic frequency was found in the APD-only arm. An afferent system of duplicate amperometric sensors demonstrated a high degree of accuracy; the mean absolute relative difference of the sensor used to control the algorithm was 9.6 ± 0.5%. We conclude that an adaptive algorithm that frequently estimates insulin sensitivity and adjusts gain factors is capable of minimizing corticosteroid-induced stress hyperglycemia.
© 2011 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22226248      PMCID: PMC3262697          DOI: 10.1177/193229681100500602

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  37 in total

1.  Theoretical blood glucose control in hyper- and hypoglycemic and exercise scenarios by means of an H(infinity) algorithm.

Authors:  G Quiroz; R Femat
Journal:  J Theor Biol       Date:  2009-12-03       Impact factor: 2.691

2.  Development of a clinical type 1 diabetes metabolic system model and in silico simulation tool.

Authors:  Xing-Wei Wong; J Geoffrey Chase; Christopher E Hann; Thomas F Lotz; Jessica Lin; Aaron J Le; Geoffrey M Shaw
Journal:  J Diabetes Sci Technol       Date:  2008-05

3.  Integral-based parameter identification for long-term dynamic verification of a glucose-insulin system model.

Authors:  Christopher E Hann; J Geoffrey Chase; Jessica Lin; Thomas Lotz; Carmen V Doran; Geoffrey M Shaw
Journal:  Comput Methods Programs Biomed       Date:  2005-03       Impact factor: 5.428

Review 4.  Glucocorticoids and insulin resistance: old hormones, new targets.

Authors:  R C Andrews; B R Walker
Journal:  Clin Sci (Lond)       Date:  1999-05       Impact factor: 6.124

5.  Factors influencing the effectiveness of glucagon for preventing hypoglycemia.

Authors:  Jessica R Castle; Julia M Engle; Joseph El Youssef; Ryan G Massoud; W Kenneth Ward
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

6.  A bihormonal closed-loop artificial pancreas for type 1 diabetes.

Authors:  Firas H El-Khatib; Steven J Russell; David M Nathan; Robert G Sutherlin; Edward R Damiano
Journal:  Sci Transl Med       Date:  2010-04-14       Impact factor: 17.956

7.  An insulin infusion advisory system based on autotuning nonlinear model-predictive control.

Authors:  Konstantia Zarkogianni; Andriani Vazeou; Stavroula G Mougiakakou; Aikaterini Prountzou; Konstantina S Nikita
Journal:  IEEE Trans Biomed Eng       Date:  2011-05-27       Impact factor: 4.538

8.  Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients.

Authors:  J E Henriksen; F Alford; G M Ward; H Beck-Nielsen
Journal:  Diabetologia       Date:  1997-12       Impact factor: 10.122

9.  Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action.

Authors:  R A Rizza; L J Mandarino; J E Gerich
Journal:  J Clin Endocrinol Metab       Date:  1982-01       Impact factor: 5.958

10.  In silico evaluation platform for artificial pancreatic beta-cell development--a dynamic simulator for closed-loop control with hardware-in-the-loop.

Authors:  Eyal Dassau; Cesar C Palerm; Howard Zisser; Bruce A Buckingham; Lois Jovanovic; Francis J Doyle
Journal:  Diabetes Technol Ther       Date:  2009-03       Impact factor: 6.118

View more
  13 in total

1.  Model-based closed-loop glucose control in type 1 diabetes: the DiaCon experience.

Authors:  Signe Schmidt; Dimitri Boiroux; Anne Katrine Duun-Henriksen; Laurits Frøssing; Ole Skyggebjerg; John Bagterp Jørgensen; Niels Kjølstad Poulsen; Henrik Madsen; Sten Madsbad; Kirsten Nørgaard
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

2.  Factors affecting the success of glucagon delivered during an automated closed-loop system in type 1 diabetes.

Authors:  P A Bakhtiani; J El Youssef; A K Duell; D L Branigan; P G Jacobs; M R Lasarev; J R Castle; W K Ward
Journal:  J Diabetes Complications       Date:  2014-09-16       Impact factor: 2.852

3.  Use of a food and drug administration-approved type 1 diabetes mellitus simulator to evaluate and optimize a proportional-integral-derivative controller.

Authors:  Srinivas Laxminarayan; Jaques Reifman; Garry M Steil
Journal:  J Diabetes Sci Technol       Date:  2012-11-01

4.  Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes.

Authors:  Firas H El-Khatib; Steven J Russell; Kendra L Magyar; Manasi Sinha; Katherine McKeon; David M Nathan; Edward R Damiano
Journal:  J Clin Endocrinol Metab       Date:  2014-01-31       Impact factor: 5.958

5.  Quantification of the glycemic response to microdoses of subcutaneous glucagon at varying insulin levels.

Authors:  Joseph El Youssef; Jessica R Castle; Parkash A Bakhtiani; Ahmad Haidar; Deborah L Branigan; Matthew Breen; W Kenneth Ward
Journal:  Diabetes Care       Date:  2014-08-19       Impact factor: 19.112

Review 6.  Safe glycemic management during closed-loop treatment of type 1 diabetes: the role of glucagon, use of multiple sensors, and compensation for stress hyperglycemia.

Authors:  W Kenneth Ward; Jessica R Castle; Joseph El Youssef
Journal:  J Diabetes Sci Technol       Date:  2011-11-01

7.  Outpatient glycemic control with a bionic pancreas in type 1 diabetes.

Authors:  Steven J Russell; Firas H El-Khatib; Manasi Sinha; Kendra L Magyar; Katherine McKeon; Laura G Goergen; Courtney Balliro; Mallory A Hillard; David M Nathan; Edward R Damiano
Journal:  N Engl J Med       Date:  2014-06-15       Impact factor: 91.245

Review 8.  A review of artificial pancreas technologies with an emphasis on bi-hormonal therapy.

Authors:  P A Bakhtiani; L M Zhao; J El Youssef; J R Castle; W K Ward
Journal:  Diabetes Obes Metab       Date:  2013-04-21       Impact factor: 6.577

9.  Challenges and Recent Progress in the Development of a Closed-loop Artificial Pancreas.

Authors:  B Wayne Bequette
Journal:  Annu Rev Control       Date:  2012-12       Impact factor: 6.091

10.  Automated control of an adaptive bihormonal, dual-sensor artificial pancreas and evaluation during inpatient studies.

Authors:  Peter G Jacobs; Joseph El Youssef; Jessica Castle; Parkash Bakhtiani; Deborah Branigan; Matthew Breen; David Bauer; Nicholas Preiser; Gerald Leonard; Tara Stonex; W Kenneth Ward
Journal:  IEEE Trans Biomed Eng       Date:  2014-05-13       Impact factor: 4.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.